1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Inclusions & Exclusions
1.4 Market Scope
1.4.1 Markets Covered
1.4.2 Regions Covered
1.4.3 Years Considered
1.4.4 Currency Considered
Table 1 Exchange Rates Utilized for Conversion to USD
1.5 Stakeholders
1.6 Summary of Changes
1.6.1 Recession Impact: Particle Therapy Market
2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Primary Sources
2.1.2.2 Key Data from Primary Sources
2.1.2.3 Breakdown of Primaries
Figure 2 Breakdown of Primary Interviews (Supply-Side): by Company Type, Designation, and Region
Figure 3 Breakdown of Primary Interviews (Demand-Side): by End-user, Designation, and Region
2.1.2.4 Key Industry Insights
2.2 Market Size Estimation
Figure 4 Market Size Estimation: Revenue Share Analysis, 2022
Figure 5 Supply-Side Analysis
Figure 6 Top-Down Approach
Figure 7 CAGR Projections from Analysis of Drivers, Restraints, Opportunities, and Challenges
Figure 8 CAGR Projections
2.3 Market Breakdown and Data Triangulation
Figure 9 Data Triangulation Methodology
2.4 Research Limitations
2.4.1 Scope-Related Limitations
2.4.2 Methodology-Related Limitations
2.5 Risk Assessment
2.6 Study Assumptions
2.6.1 Impact of Recession on Particle Therapy Market
3 Executive Summary
Figure 10 Particle Therapy Market, by Type, 2023 vs. 2028 (USD Million)
Figure 11 Particle Therapy Market, by Product & Service, 2023 vs. 2028 (USD Million)
Figure 12 Particle Therapy Products Market, by Type, 2023 vs. 2028 (USD Million)
Figure 13 Particle Therapy Market, by System, 2023 vs. 2028 (USD Million)
Figure 14 Particle Therapy Market, by Cancer Type, 2023 vs. 2028 (USD Million)
Figure 15 Particle Therapy Market, by Application, 2023 vs. 2028 (USD Million)
Figure 16 Geographical Snapshot of Particle Therapy Market
4 Premium Insights
4.1 Particle Therapy Market Overview
Figure 17 Increasing Prevalence of Cancer to Drive Market
4.2 Regional Mix: Particle Therapy Market
Figure 18 Asia-Pacific to Register Highest Growth Rate During Study Period
4.3 Asia-Pacific: Particle Therapy Market, by Type and Country (2022)
Figure 19 Proton Therapy Accounted for the Largest Share of the Asia-Pacific Market in 2022
4.4 Particle Therapy Market: Geographic Growth Opportunities
Figure 20 China to Register Highest CAGR During Forecast Period
4.5 Developed vs. Emerging Economies: Particle Therapy Market
Figure 21 Emerging Economies to Register Higher Growth During Forecast Period
5 Market Overview
5.1 Introduction
Figure 22 Particle Therapy Market: Drivers, Restraints, Opportunities, and Challenges
5.1.1 Drivers
5.1.1.1 Advantages of Particle Therapy Over Photon Therapy
5.1.1.2 Growing Prevalence of Cancer
5.1.1.3 Rising Adoption of Particle Therapy in Clinical Trials
5.1.1.4 Increasing Number of Particle Therapy Centers Worldwide
5.1.1.5 Technological Advancements
5.1.2 Restraints
5.1.2.1 Infrastructural Challenges in Healthcare Facilities
5.1.2.2 Affordability and Accessibility of Treatments
5.1.2.3 Unfavorable Reimbursement Policies and Limited Insurance Coverage for Particle Therapy
5.1.3 Opportunities
5.1.3.1 Growth Potential of Emerging Economies
5.1.4 Challenges
5.1.4.1 Difficulties in Visualizing Tumors During Particle Therapy Procedures
5.1.4.2 Potential for Unwanted Radiation Exposure
5.2 Ecosystem/Market Map
Figure 23 Particle Therapy Market: Ecosystem Analysis
5.3 Pricing Analysis
5.4 Supply Chain Analysis
Figure 24 Supply Chain Analysis: Particle Therapy Market
5.5 Patent Analysis
5.5.1 Patent Publication Trends for Particle Therapy Market
Figure 25 Total Patents Granted from 2012-2022
Figure 26 Top Patent Applicants in Particle Therapy
Figure 27 Top Patent Owners in Particle Therapy
5.6 Value Chain Analysis
Figure 28 Particle Therapy Market: Value Chain Analysis
5.7 Technology Analysis
5.8 Key Conferences & Events in 2023-2024
5.9 Regulatory Landscape
Table 2 North America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 3 Europe: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 4 Asia-Pacific: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 5 Rest of the World: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 6 Regulatory Standards/Approvals Required for Particle Therapy Products by Country/Region
5.10 Reimbursement Analysis
Table 7 Medical Reimbursement Codes for Particle Therapy Procedures in US, 2022
5.11 Trade Analysis
Table 8 Installed Base of Radiotherapy Devices
5.12 Porter's Five Forces Analysis
Table 9 Particle Therapy Market: Porter's Five Forces Analysis
5.12.1 Threat of New Entrants
5.12.2 Threat of Substitutes
5.12.3 Bargaining Power of Suppliers
5.12.4 Bargaining Power of Buyers
5.12.5 Degree of Competition
5.13 Key Stakeholders & Buying Criteria
5.13.1 Key Stakeholders in the Buying Process
Figure 29 Influence of Stakeholders on the Buying Process for Top Three Applications
Table 10 Influence of Stakeholders on the Buying Process for Top Three Applications (%)
5.13.2 Buying Criteria
Figure 30 Key Buying Criteria for Top Three Applications
Table 11 Key Buying Criteria for Top Three Applications
5.14 Case Study Analysis
Table 12 Case Study: Enhancing Patient Safety - Rt's Role in Minimizing Radiation Risk in an Elderly Patient (90-Year-Old Female with a Medically Inoperable Early-Stage Nsclc)
5.15 Trends/Disruptions Impacting Customer's Business
Figure 31 Emerging Trends and Opportunities Affecting Future Revenue Mix
6 Particle Therapy Market, by Product & Service
6.1 Introduction
Table 13 Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
6.2 Products
Table 14 Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
Table 15 Particle Therapy Products Market, by Region, 2021-2028 (USD Million)
6.2.1 Cyclotrons
6.2.1.1 Advantages Offered by Cyclotrons Over Other Accelerators to Drive Market
Table 16 Cyclotrons Market, by Region, 2021-2028 (USD Million)
Table 17 North America: Cyclotrons Market, by Country, 2021-2028 (USD Million)
Table 18 Europe: Cyclotrons Market, by Country, 2021-2028 (USD Million)
Table 19 Asia-Pacific: Cyclotrons Market, by Country, 2021-2028 (USD Million)
Table 20 Latin America: Cyclotrons Market, by Country, 2021-2028 (USD Million)
6.2.2 Synchrotrons
6.2.2.1 Increasing Investments for Development of Synchrotron Facilities to Aid Market Growth
Table 21 Synchrotrons Market, by Region, 2021-2028 (USD Million)
Table 22 North America: Synchrotrons Market, by Country, 2021-2028 (USD Million)
Table 23 Europe: Synchrotrons Market, by Country, 2021-2028 (USD Million)
Table 24 Asia-Pacific: Synchrotrons Market, by Country, 2021-2028 (USD Million)
Table 25 Latin America: Synchrotrons Market, by Country, 2021-2028 (USD Million)
6.2.3 Synchrocyclotrons
6.2.3.1 High Space Requirements to Limit Adoption
Table 26 Synchrocyclotrons Market, by Region, 2021-2028 (USD Million)
Table 27 North America: Synchrocyclotrons Market, by Country, 2021-2028 (USD Million)
Table 28 Europe: Synchrocyclotrons Market, by Country, 2021-2028 (USD Million)
Table 29 Asia-Pacific: Synchrocyclotrons Market, by Country, 2021-2028 (USD Million)
Table 30 Latin America: Synchrocyclotrons Market, by Country, 2021-2028 (USD Million)
6.3 Services
6.3.1 Availability of Wide Range of Services to Propel Market
Table 31 Particle Therapy Services Market, by Region, 2021-2028 (USD Million)
Table 32 North America: Particle Therapy Services Market, by Country, 2021-2028 (USD Million)
Table 33 Europe: Particle Therapy Services Market, by Country, 2021-2028 (USD Million)
Table 34 Asia-Pacific: Particle Therapy Services Market, by Country, 2021-2028 (USD Million)
Table 35 Latin America: Particle Therapy Services Market, by Country, 2021-2028 (USD Million)
7 Particle Therapy Market, by Type
7.1 Introduction
Table 36 Particle Therapy Market, by Type, 2021-2028 (USD Million)
7.2 Proton Therapy
7.2.1 Growing Adoption as Primary Treatment for Various Cancer Types to Drive Market
Table 37 Proton Therapy Market, by Region, 2021-2028 (USD Million)
7.3 Heavy Ion Therapy
7.3.1 Slower Growth Attributed to Experimental Phase Across Many Regions
Table 38 Heavy Ion Therapy Market, by Region, 2021-2028 (USD Million)
8 Particle Therapy Market, by System
8.1 Introduction
Table 39 Particle Therapy Market, by System, 2021-2028 (USD Million)
8.2 Multi-Room Systems
8.2.1 Lower Shielding Requirements and Faster Beam-Switching Capabilities to Drive Interest Among End-users
Table 40 Particle Therapy Market for Multi-Room Systems, by Region, 2021-2028 (USD Million)
8.3 Single-Room Systems
8.3.1 Compact Structure and Reduced Capital Cost to Propel Growth
Table 41 Particle Therapy Market for Single-Room Systems, by Region, 2021-2028 (USD Million)
9 Particle Therapy Market, by Application
9.1 Introduction
Table 42 Particle Therapy Market, by Application, 2021-2028 (USD Million)
9.2 Treatment Applications
9.2.1 Introduction of Small Footprint Single-Room Particle Therapy Centers to Support Market Growth
Table 43 Particle Therapy Market for Treatment Applications, by Region, 2021-2028 (USD Million)
9.3 Research Applications
9.3.1 Increasing Availability of Funding for Particle Therapy-Related Research Projects to Provide Growth Opportunities
Table 44 Particle Therapy Market for Research Applications, by Region, 2021-2028 (USD Million)
10 Particle Therapy Market, by Cancer Type
10.1 Introduction
Table 45 Particle Therapy Market, by Cancer Type, 2021-2028 (USD Million)
10.2 Pediatric Cancer
10.2.1 Increasing Cases of Pediatric Cancer to Propel Market
Table 46 Particle Therapy Market for Pediatric Cancer, by Region, 2021-2028 (USD Million)
10.3 Prostate Cancer
10.3.1 Advantages Offered by Particle Therapy for Treatment of Prostate Cancer to Drive Market
Table 47 Particle Therapy Market for Prostate Cancer, by Region, 2021-2028 (USD Million)
10.4 Lung Cancer
10.4.1 Growing Clinical Testing of Proton Therapy for Lung Cancer to Drive Market
Table 48 Particle Therapy Market for Lung Cancer, by Region, 2021-2028 (USD Million)
10.5 Breast Cancer
10.5.1 Limited Radiation Exposure with Reduced Side-Effects to Increase Adoption of Particle Therapy
Table 49 Particle Therapy Market for Breast Cancer, by Region, 2021-2028 (USD Million)
10.6 Head & Neck Cancer
10.6.1 Use of Pencil-Beam Scanning for Proton Therapy to Support Market Growth
Table 50 Particle Therapy Market for Head & Neck Cancer, by Region, 2021-2028 (USD Million)
10.7 Other Cancers
Table 51 Particle Therapy Market for Other Cancers, by Region, 2021-2028 (USD Million)
11 Particle Therapy Market, by Region
11.1 Introduction
Table 52 Particle Therapy Market, by Region, 2021-2028 (USD Million)
11.2 North America
11.2.1 North America: Recession Impact
Figure 32 North America: Particle Therapy Market Snapshot
Table 53 North America: Particle Therapy Market, by Country, 2021-2028 (USD Million)
Table 54 North America: Particle Therapy Market, by Type, 2021-2028 (USD Million)
Table 55 North America: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 56 North America: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
Table 57 North America: Particle Therapy Market, by System, 2021-2028 (USD Million)
Table 58 North America: Particle Therapy Market, by Cancer Type, 2021-2028 (USD Million)
Table 59 North America: Particle Therapy Market, by Application, 2021-2028 (USD Million)
11.2.2 US
11.2.2.1 Growing Number of Particle Therapy Centers to Drive Market Growth
Table 60 US: Macroeconomic Indicators
Table 61 US: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 62 US: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.2.3 Canada
11.2.3.1 Government Initiative to Include Particle Therapy as Treatment Method to Boost Market
Table 63 Canada: Macroeconomic Indicators
Table 64 Canada: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 65 Canada: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.3 Europe
11.3.1 Europe: Recession Impact
Table 66 Europe: Particle Therapy Market, by Country, 2021-2028 (USD Million)
Table 67 Europe: Particle Therapy Market, by Type, 2021-2028 (USD Million)
Table 68 Europe: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 69 Europe: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
Table 70 Europe: Particle Therapy Market, by System, 2021-2028 (USD Million)
Table 71 Europe: Particle Therapy Market, by Cancer Type, 2021-2028 (USD Million)
Table 72 Europe: Particle Therapy Market, by Application, 2021-2028 (USD Million)
11.3.2 Germany
11.3.2.1 Increasing Research on Proton and Heavy Ion Therapy to Drive Market Growth
Table 73 Germany: Macroeconomic Indicators
Table 74 Germany: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 75 Germany: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.3.3 France
11.3.3.1 Increasing Healthcare Expenditure to Support Particle Therapy Product Adoption
Table 76 France: Macroeconomic Indicators
Table 77 France: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 78 France: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.3.4 UK
11.3.4.1 Increasing Acceptance of Particle Therapy Techniques in Cancer Treatment to Support Market Growth
Table 79 UK: Macroeconomic Indicators
Table 80 UK: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 81 UK: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.3.5 Italy
11.3.5.1 Increasing Awareness Activities to Support Market Growth
Table 82 Italy: Macroeconomic Indicators
Table 83 Italy: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 84 Italy: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.3.6 Spain
11.3.6.1 Increasing Number of Conferences and Government Funding for Cancer Research to Drive Market
Table 85 Spain: Macroeconomic Indicators
Table 86 Spain: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 87 Spain: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.3.7 Rest of Europe
Table 88 Rest of Europe: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 89 Rest of Europe: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.4 Asia-Pacific
11.4.1 Asia-Pacific: Recession Impact
Figure 33 Asia-Pacific: Particle Therapy Market Snapshot
Table 90 Asia-Pacific: Particle Therapy Market, by Country, 2021-2028 (USD Million)
Table 91 Asia-Pacific: Particle Therapy Market, by Type, 2021-2028 (USD Million)
Table 92 Asia-Pacific: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 93 Asia-Pacific: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
Table 94 Asia-Pacific: Particle Therapy Market, by System, 2021-2028 (USD Million)
Table 95 Asia-Pacific: Particle Therapy Market, by Cancer Type, 2021-2028 (USD Million)
Table 96 Asia-Pacific: Particle Therapy Market, by Application, 2021-2028 (USD Million)
11.4.2 Japan
11.4.2.1 Increasing Use of Heavy Ion Therapy for Cancer Treatment to Propel Market
Table 97 Japan: Macroeconomic Indicators
Table 98 Japan: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 99 Japan: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.4.3 China
11.4.3.1 High Cancer Burden to Drive Market
Table 100 China: Macroeconomic Indicators
Table 101 China: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 102 China: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.4.4 India
11.4.4.1 Improving Research Capabilities to Support Market Growth
Table 103 India: Macroeconomic Indicators
Table 104 India: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 105 India: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.4.5 Australia
11.4.5.1 Healthcare Funding Availability to Boost Market Growth
Table 106 Australia: Macroeconomic Indicators
Table 107 Australia: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 108 Australia: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.4.6 South Korea
11.4.6.1 Rising Prevalence of Cancer to Drive Market
Table 109 South Korea: Macroeconomic Indicators
Table 110 South Korea: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 111 South Korea: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.4.7 Rest of Asia-Pacific
Table 112 Rest of Asia-Pacific: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 113 Rest of Asia-Pacific: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.5 Latin America
11.5.1 Latin America: Recession Impact
Table 114 Latin America: Particle Therapy Market, by Country, 2021-2028 (USD Million)
Table 115 Latin America: Particle Therapy Market, by Type, 2021-2028 (USD Million)
Table 116 Latin America: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 117 Latin America: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
Table 118 Latin America: Particle Therapy Market, by System, 2021-2028 (USD Million)
Table 119 Latin America: Particle Therapy Market, by Cancer Type, 2021-2028 (USD Million)
Table 120 Latin America: Particle Therapy Market, by Application, 2021-2028 (USD Million)
11.5.2 Brazil
11.5.2.1 Government Initiates to Propel Market Growth
Table 121 Brazil: Macroeconomic Indicators
Table 122 Brazil: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 123 Brazil: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.5.3 Mexico
11.5.3.1 Growing Adoption of Advanced Medical Technologies to Drive Market
Table 124 Mexico: Macroeconomic Indicators
Table 125 Mexico: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 126 Mexico: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.5.4 Rest of Latin America
Table 127 Rest of Latin America: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 128 Rest of Latin America: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
11.6 Middle East & Africa
11.6.1 Improving Healthcare Infrastructure and Increasing Public-Private Investments to Drive Market
11.6.2 Middle East & Africa: Recession Impact
Table 129 Middle East & Africa: Particle Therapy Market, by Type, 2021-2028 (USD Million)
Table 130 Middle East & Africa: Particle Therapy Market, by Product & Service, 2021-2028 (USD Million)
Table 131 Middle East & Africa: Particle Therapy Products Market, by Type, 2021-2028 (USD Million)
Table 132 Middle East & Africa: Particle Therapy Market, by System, 2021-2028 (USD Million)
Table 133 Middle East & Africa: Particle Therapy Market, by Cancer Type, 2021-2028 (USD Million)
Table 134 Middle East & Africa: Particle Therapy Market, by Application, 2021-2028 (USD Million)
12 Competitive Landscape
12.1 Overview
12.2 Strategies Adopted by Key Players
Figure 34 Key Developments in Particle Therapy Market
12.3 Revenue Share Analysis of Top Market Players
Figure 35 Revenue Analysis of Top Players in Particle Therapy Market
12.4 Market Share Analysis
Figure 36 Market Share Analysis, by Key Player, 2022
12.5 Company Evaluation Matrix
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants
Figure 37 Particle Therapy Market: Company Evaluation Matrix, 2022
12.6 Competitive Benchmarking for Key Players
12.6.1 Particle Therapy Market: Company Footprint
Table 135 Overall Company Footprint (10 Companies)
Table 136 Type Footprint (10 Companies)
Table 137 Product & Service Footprint (10 Companies)
Table 138 System Footprint (10 Companies)
Table 139 Cancer Type Footprint (10 Companies)
Table 140 Application Footprint (10 Companies)
Table 141 Regional Footprint (10 Companies)
12.7 Startup/SME Evaluation Matrix
12.7.1 Progressive Companies
12.7.2 Responsive Companies
12.7.3 Dynamic Companies
12.7.4 Starting Blocks
Figure 38 Particle Therapy Market: Startup/SME Evaluation Matrix, 2022
12.7.5 Competitive Benchmarking for Startups/SMEs
Table 142 Overall Company Footprint
Table 143 Type Footprint
Table 144 Product & Service Footprint
Table 145 System Footprint
Table 146 Cancer Type Footprint
Table 147 Application Footprint
Table 148 Regional Footprint
12.8 Competitive Scenarios & Trends
12.8.1 Product Launches & Approvals
Table 149 Particle Therapy Market: Product Launches & Approvals (January 2020-August 2023)
12.8.2 Deals
Table 150 Particle Therapy Market: Deals (January 2020-August 2023)
12.8.3 Other Developments
Table 151 Particle Therapy Market: Other Developments (January 2020-August 2023)
13 Company Profiles
13.1 Key Players
Business Overview, Products/Services/Solutions Offered, Analyst's View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments
13.1.1 Iba Worldwide
Table 152 Iba Worldwide: Business Overview
Figure 39 Iba Worldwide: Company Snapshot (2022)
13.1.2 Varian Medical Systems, Inc.
Table 153 Varian Medical Systems, Inc.: Business Overview
Figure 40 Varian Medical Systems, Inc.: Company Snapshot (2022)
13.1.3 Hitachi, Ltd.
Table 154 Hitachi, Ltd.: Business Overview
Figure 41 Hitachi, Ltd.: Company Snapshot (2021)
13.1.4 Mevion Medical Systems
Table 155 Mevion Medical Systems: Business Overview
13.1.5 Sumitomo Heavy Industries Ltd.
Table 156 Sumitomo Heavy Industries Ltd.: Business Overview
Figure 42 Sumitomo Heavy Industries Ltd.: Company Snapshot (2021)
13.1.6 Provision Healthcare, LLC
Table 157 Provision Healthcare, LLC: Business Overview
13.1.7 Toshiba Medical Systems Corporation
Table 158 Toshiba Medical Systems Corporation: Business Overview
Figure 43 Toshiba Medical Systems Corporation: Company Snapshot (2022)
13.1.8 Optivus Proton Therapy, Inc.
Table 159 Optivus Proton Therapy, Inc.: Business Overview
13.1.9 Protom International, Inc.
Table 160 Protom International, Inc.: Business Overview
13.1.10 Advanced Oncotherapy PLC
Table 161 Advanced Oncotherapy PLC: Business Overview
13.2 Other Players
13.2.1 Danfysik A/S
Table 162 Danfysik A/S: Business Overview
13.2.2 P-Cure, Ltd.
Table 163 P-Cure, Ltd.: Business Overview
13.2.3 Ptw Freiburg GmbH
Table 164 Ptw Freiburg GmbH: Business Overview
Business Overview, Products/Services/Solutions Offered, Analyst's View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments Might Not be Captured in Case of Unlisted Companies.
14 Appendix
14.1 Discussion Guide
14.2 Knowledgestore: The Subscription Portal
14.3 Customization Options
